Allelic Imbalance Analysis Using a Single-Nucleotide Polymorphism Microarray for the Detection of Bladder Cancer Recurrence

Purpose: Non–muscle-invasive bladder cancer is a frequently occurring cancer, with an extremely high recurrence risk. Recurrence detection is based on cytology and urethrocystoscopy. A previous study suggested that a single-nucleotide polymorphism (SNP) array may be effective for noninvasive detection of allelic imbalances in urine. We investigated whether this method is suitable to detect allelic imbalance as an indicator of recurrences in non–muscle-invasive bladder cancer follow-up. Experimental Design: DNA from blood and urine from 158 patients (113 with and 45 without recurrence) was hybridized to the Affymetrix GeneChip Mapping 10K 2.0. Allelic imbalance detection was based on SNPs showing changes from heterozygosity in blood to homozygosity in urine and on automatic analysis of copy number changes using Copy Number Analyser for GeneChip. Results: Urine samples with tumor showed allelic imbalance at 0.4% of all informative SNPs. In samples without tumors, 0.04% of these SNPs were affected (P = 0.07). In addition, Copy Number Analyser for GeneChip analysis showed more copy number changes in samples with a tumor (P = 0.001). Losses and gains of chromosomal regions showed clustering, overlapping with known bladder cancer loci. However, 25 (22%) patients with a tumor recurrence did not display any regions with copy number changes, whereas 24 (53%) individuals without a recurrence did. Receiver operating characteristic curve analysis using the number of SNPs displaying copy number changes from the Copy Number Analyser for GeneChip analysis resulted in an area under the curve of only 0.67 (95% confidence interval, 0.58-0.76). Conclusion: Single-nucleotide polymorphism microarray analysis of allelic imbalance in urine cannot replace urethrocystoscopy and cytology for the detection of recurrences in non–muscle-invasive bladder cancer follow-up.

[1]  C. Chelala,et al.  Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays , 2008, Oncogene.

[2]  I. Kovalszky,et al.  Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment. , 2007, Oncology reports.

[3]  H. Moch,et al.  Improved detection of bladder carcinoma cells in voided urine by standardized microsatellite analysis , 2007, International journal of cancer.

[4]  N. Malats,et al.  Epidemiology of urinary bladder cancer: from tumor development to patient’s death , 2007, World Journal of Urology.

[5]  M. Meyerson,et al.  Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays , 2007, PloS one.

[6]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[7]  P. Carroll,et al.  Bladder cancer stage and outcome by array-based comparative genomic hybridization. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  G. Rossi,et al.  Prevalence and prognostic significance of microsatellite alterations in young patients with bladder cancer , 2005, Modern Pathology.

[9]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[10]  R. Montironi,et al.  Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features. , 2005, Analytical and quantitative cytology and histology.

[11]  Balraj Mittal,et al.  Microsatellite instability as prognostic marker in bladder tumors: a clinical significance , 2005, BMC urology.

[12]  Carsten Wiuf,et al.  High-density single nucleotide polymorphism array defines novel stage and location-dependent allelic imbalances in human bladder tumors. , 2005, Cancer research.

[13]  R. Knuechel,et al.  Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. , 2005, European urology.

[14]  Liang Cheng,et al.  Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder , 2004, Cancer.

[15]  N. Carter,et al.  High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization , 2004, Oncogene.

[16]  Jing Huang,et al.  Parallel genotyping of over 10,000 SNPs using a one-primer assay on a high-density oligonucleotide array. , 2004, Genome research.

[17]  Jörg Schmidbauer,et al.  Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. , 2004, The Journal of urology.

[18]  W. Schulze,et al.  Analysis of genetic alterations in normal bladder urothelium. , 2003, Urology.

[19]  Keishi Yamashita,et al.  High-throughput molecular analysis of urine sediment for the detection of bladder cancer by high-density single-nucleotide polymorphism array. , 2003, Cancer research.

[20]  Marije Deutekom,et al.  Tumor markers in the diagnosis of primary bladder cancer. A systematic review. , 2003, The Journal of urology.

[21]  Wen-Lin Kuo,et al.  Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. , 2003, Cancer research.

[22]  Paul Cairns,et al.  Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. , 2003, Cancer research.

[23]  R. Knuechel,et al.  Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses , 2003, The Journal of pathology.

[24]  C. Roehrborn,et al.  Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. , 2003, Urology.

[25]  H. Klocker,et al.  Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. , 2002, European urology.

[26]  Arndt Hartmann,et al.  Molecular genetic evaluation of fluorescence diagnosis in bladder cancer. , 2002, International journal of oncology.

[27]  H. von der Maase,et al.  Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. , 2002, Journal of the National Cancer Institute.

[28]  W. Schulz,et al.  Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder , 2001, British Journal of Cancer.

[29]  Burger,et al.  Genetic alterations and biological pathways in human bladder cancer pathogenesis. , 2000, Urologic oncology.

[30]  S. Muto,et al.  Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer. , 2000, Cancer research.

[31]  F. M. Brown,et al.  URINE CYTOLOGY: Is it Still the Gold Standard for Screening? , 2000 .

[32]  A Hofstetter,et al.  Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. , 1999, The American journal of pathology.

[33]  C. Cordon-Cardo.  Molecular alterations in bladder cancer. , 1998, Cancer surveys.

[34]  T. Ørntoft,et al.  Molecular alterations in bladder cancer , 1998, Urological Research.

[35]  Koss Lg.  Errors and pitfalls in cytology of the lower urinary tract. , 1997 .

[36]  L. Koss.  Errors and pitfalls in cytology of the lower urinary tract. , 1997, Monographs in pathology.

[37]  N. Heney,et al.  Natural history of superficial bladder cancer. Prognostic features and long-term disease course. , 1992, The Urologic clinics of North America.

[38]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[39]  L. Koss,et al.  Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. , 1984, Analytical and quantitative cytology.